Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
263,011,603
-
Share change
-
+257,396,991
-
Total reported value
-
$7,746,679,299
-
Put/Call ratio
-
55%
-
Price per share
-
$29.43
-
Number of holders
-
683
-
Value change
-
+$7,578,084,379
-
Number of buys
-
636
-
Number of sells
-
51
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q3 2022
As of 30 Sep 2022,
GSK plc - SPONSORED ADR (GSK) was held by
683 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
263,011,603 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, STATE STREET CORP, and TWO SIGMA INVESTMENTS, LP.
This page lists
691
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.